Exploratory Study of Cerebral Perfusion and Metabolic Alterations and Neurocognitive Disorders in Patients With Unruptured Arteriovenous Malformations Before and After Surgical Treatment

ConditionUnruptured Brain Arteriovenous Malformation

Trial statusNot yet recruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18+

SponsorUniversity Hospital, Montpellier

About this trial

The goal of the clinical trial is to describe perfusion and metabolic alterations in different brain regions before and six months after surgical treatment of arteriovenous malformations in adult patients with unruptured arteriovenous malformations.

Eligibility criteria

Qualifiers

Adults aged 18 and older

Admitted for an unruptured arteriovenous malformation with a decision to proceed with surgery

Disqualifiers

Patients who refuse surgical treatment for arteriovenous malformation

Contraindications to 18F-FDG PET (uncontrolled diabete)

Patients' inability to lie still for 40 minutes

Patients with a confirmed diagnosis of neurodegenerative or psychiatric disorders

Trial design

Treatments tested in this trial

18F-FDG PET imaging
Neuropsychological Assessment

Treatment groups

10 Participants

are divided into 1 treatment group

Sponsors and collaborators

University Hospital, Montpellier

Lead sponsor

Source ClinicalTrials.gov